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ABSTRACTS
The treatment of chondral knee injuries remains a chal-
lenge for the orthopedic surgeon, mainly owing to the 
characteristics of the cartilage tissue, which promote low 
potential for regeneration. Chondral lesions can be caused 
by metabolic stimulation, or by genetic, vascular and trau-
matic events, and are classified according to the size and 
thickness of the affected cartilage. Clinical diagnosis can 
be difficult, especially due to insidious symptoms. Ad-
ditional tests, as Magnetic Resonance Imaging (MRI), 
may be needed. The treatment of these lesions usually 
starts with non-operative management. Surgery should be 
reserved for patients with detached chondral fragments, 
blocked range of motion, or the failure of non-operative 
treatment. The surgical techniques used for the treatment 
of partial thickness defects are Debridement and Ablation. 
These techniques aim to improve symptoms, since they do 
not restore normal structure and function of the cartilage. 
For full-thickness defects (osteochondral lesion), available 
treatments are Abrasion, Drilling, Microfracture, Osteo-
chondral Autologous and Allogeneic Transplantation, and 
biological techniques such as the use of Autologous Chon-
drocyte Transplantation, Minced Cartilage and stem cells.
Keywords - Cartilage Diseases; Knee; Arthroscopy; Articular 
Cartilage 
INTRODUCTION
The knee is a diarthrodial joint formed by two joint 
surfaces: the tibiofemoral and patellofemoral surfaces. 
The medial and lateral tibiofemoral compartments, 
together with the patellofemoral joint, form the three 
compartment of the knee, and these are covered by 
hyaline joint cartilage(1). 
Hyaline joint cartilage is a kind of dense conjunc-
tive tissue consisting of cells, water and matrix. The 
tissue is well-structured and elastic, with a smooth 
white surface. The main functions of joint cartilage 
are to protect the subchondral bone, allow the contact 
surfaces to slide across each other without friction and 
absorb impact(2-5).
Hyaline cartilage is composed mainly of chondro-
cytes surrounded by an extracellular matrix(3-6). This 
matrix is synthesized and secreted by the chondro-
cytes and is composed mainly by type II collagen 
fibers, proteoglycans and water(4,6). Morphologically, 
hyaline cartilage has four layers: superfi cial, interme-
diate, deep and calcified layers(3). The biomechanical 
properties of the joint cartilage are largely dependent 
on the composition and integrity of the extracellular 
matrix. Joint cartilage tissue is hypocellular, avascu-
lar, aneural and non-lymphatic, which diminishes the 
possibility of tissue regeneration(3,6).
Chondral lesions are caused through degradation 
of joint cartilage, in response to metabolic, genetic, 
vascular and traumatic stimuli. They can occur be-
cause of a single episode of overload on the knee 
joint, or through several cyclical episodes of small 
magnitude. These lesions are subdivided according to 
the cartilage thickness affected, and go from microle-
sions and chondral lesions to osteochondral lesions 
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that involve all layers of the joint cartilage and affect 
the subchondral bone(7).
Osteochondral lesions in patients with healthy carti-
lage generally have a traumatic origin. Although some 
chondral lesions are asymptomatic, they may evolve 
with cartilage degeneration and osteoarthrosis(8). 
Classification of chondral lesions
Joint cartilage defects are differentiated into two 
categories: defects of partial thickness and those of 
full thickness (osteochondral defects)(5).
In 1961, Outerbridge(9) classified macroscopic 
joint cartilage abnormalities into four grades: gra-
de I, softening of the cartilage; grade II, fragmen-
tation and fissuring over an area of half an inch in 
diameter or less (1.5 cm in diameter or less); grade 
III, this process increases to involve an area greater 
than half an inch in diameter (greater than 1.5 cm in 
diameter); and grade IV, a lesion compromising the 
entire thickness of the cartilage, with exposure of the 
subchondral bone. 
The International Cartilage Repair Society 
(ICRS) system for evaluating cartilage repairs was 
developed from the work by Brittberg et al(10). The 
scoring system for macroscopically assessing car-
tilage defect repairs was then described more com-
prehensively by Peterson et al(11). This classification 
was adopted and simplified by the ICRS and has 
been used for assessing the grades of chondral le-
sions(12) (Table 1).
Epidemiology
The real incidence of osteochondral lesions in hu-
mans is unknown, because a large proportion of them are 
asymptomatic. In an attempt to estimate their incidence, 
two large studies were conducted retrospectively(13,14). 
In the study by Curl et al(13), it was observed that 
41% of the patients with chondral lesions that were 
detected during arthroscopy presented fragmentation 
and fissuring over an area greater than half an inch 
in diameter (grade III Outerbridge chondral lesions) 
and 19.2% presented cartilage erosion involving sub-
chondral bone (grade IV Outerbridge chondral lesions). 
According to this study, 20% of the chondral lesions 
classified as grade IV are located in the medial femoral 
condyle, and 72% of the cases of grade IV chondral 
lesions are found in patients over the age of 40 years.
In the study by Widuchowski et al(14), some type of 
chondral lesion was found in 60% of the knees ope-
rated, of which 67% were classified as osteochondral 
or chondral lesions, 29% as osteoarthritis, 2% as oste-
ochondritis dissecans and 1% as other types. Lesions 
that were not limited to the cartilage occurred in 70% of 
the cases, while lesion thus limited accounted for 30%. 
The most frequent locations were the joint surface 
of the patella (36%) and the medial femoral condy-
le (34%). Lesions classified as grade II according to 
Outerbridge were the most frequent type, occurring in 
42% of the cases. The type of lesion most commonly 
associated with chondral lesions was tearing of the 
medial meniscus, in 42%, followed by lesions of the 
anterior cruciate ligament, in 36%. 
DIAGNOSIS
Clinical – The clinical diagnosis may be difficult 
to make, since the symptoms are poor. The most 
frequent complaints are pain, joint effusion, lockage 
and crepitation. The symptoms are generally insi-
dious, with diffuse or specific pain at the joint inter-
line and in the anterior region of the knee(7). Some 
provocative tests can be performed to diagnose the 
lesion, such as the Wilson test, which identifies os-
teochondritis dissecans in the medial condyle(15).
Radiological (X-ray) – The radiological diagnosis 
may be important for ruling out other pathological 
conditions and associated lesions, such as degen-
erative lesions (presence of osteophytes, cysts, sub-
chondral sclerosis and joint space reduction)(16) and 
fractures. It may also make it possible to view com-
plete chondral lesions with loose fragments in the 
Table 1 – Classification of chondral lesions according to the 
ICRS system.
Normal Grade 0
Almost normal
Grade 1a – superficial lesions/softening
Grade 1b – As in 1a and/or superficial fissures or 
cracks
Abnormal Grade 2 – extent < 50% of thickness
Severe lesion
Grade 3a – extent > 50%
Grade 3b – down to the calcified layer
Grade 3c – down to the surface of the subchondral 
bone (without penetration)
Grade 3d – includes bulging of the cartilage around 
the lesion
Very severe 
lesion
Grade 4a – penetration of the subchondral bone 
but not across the entire diameter of the defect
Grade 4b – penetration across the full diameter of 
the defect
14
Figure 1 - NMR with T1 weighting (A) and T2 weighting (B) on the patient of the radiographs in photo 1 (B and C), showing appear-
ance of chondral lesion that was not seen on the radiographs. The lesion is seen better with T2 weighting.
BA
A B C
Figure 2 – Showing at letter A, cartilage without lesion; B, grade III chondral lesion; C, grade IV osteochondral lesion.
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joint cavity, i.e. the pathological condition known as 
osteochondritis dissecans.  
Tomography and arthrotomography – These basically 
have the same diagnostic indications as radiography, and 
injection of intra-articular contrast (arthrotomography) 
directly demonstrates the presence of chondral lesions. 
With the advent of nuclear magnetic resonance, this ex-
amination is no longer considered to be the gold standard. 
Moreover, there are risks involved in injecting contrast 
into the joint. 
nuclear magnetic resonance (nmR) – Magnetic reso-
nance, with its excellent contrast in soft tissue, is the best 
imaging technique available for studying cartilage le-
sions (18). It enables morphological evaluation of the sur-
face, thickness, volume and subchondral bone (Figure 1).
Arthroscopy – This is the gold standard examina-
tion for intra-articular pathological conditions of the 
knee(19). Through using this tool, lesions can be clas-
sified, located and palpated (Figure 2).
Conservative treatment
Conservative procedures are generally the first ap-
proach for treating the symptoms of knee injuries, 
and these include physiotherapy, weight loss and sys-
temic medications for pain relief(20). Physiotherapy 
maintains the range of motion, promotes nutrition 
for the cartilage and strengthens the affected limb(21) . 
The medications that have been used for pain relief 
include analgesics and non-steroid anti-inflammatory 
drugs (NSAIDs). 
SURGICAL TREATMENT 
Partial defects
Non-reparative and non-restorative surgical tech-
niques such as debridement and radiofrequency me-
thods can be used. These have the aim of promoting 
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a surface with more evenness(22). Such procedures are 
performed arthroscopically, in order to minimize the 
pain and improve mobility, but they do not completely 
restore the cartilage structure and functions(23).  
Debridement
Debridement has commonly been used in treating 
osteoarthrosis, but it can also be used to treat purely 
chondral defects. The debridement procedure was 
established by Magnuson in 1941 apud Day(24). The 
procedure used for partial chondral lesions involves 
removal of fragments such as unstable chondral flaps, 
osteophytes, excess synovium, degenerated menisci 
and torn ligaments(22). It is generally done using a 
shaver, but other methods such as electrocautery, laser 
or radiofrequency techniques may also be used(25). 
The aim of debridement is to eliminate symptoms, 
thus promoting pain relief and improved function. 
However, the symptoms can be expected to return(22). 
Radiofrequency
One alternative used for treating partial chondral 
lesions is radiofrequency, which has become very 
popular because this technique is easy to use ar-
throscopically and is effective for achieving an even 
surface across partial chondral lesions. However, the 
high intra-articular temperature associated with this 
method may have the potential to partially or com-
pletely destroy the joint cartilage(25). Temperatures 
higher than 50°C have been defined as a critical 
threshold for chondrocyte death(26). Occurences of 
necrosis associated with radiofrequency use depend 
on the quantity and duration of application of the 
energy(27). The ideal technique for using radiofre-
quency devices is to use them like paintbrushes, in 
which they are kept in continual movement. Using 
this type of application, with two different types 
of radiofrequency, Amil et al(28) demonstrated that 
chondrocytes remained intact and active at a depth 
of 100-200 µm below the treatment location. Over 
recent years, radiofrequency devices with tempera-
ture indicators have been developed, so that tem-
peratures can be monitored during arthroscopy(29).
Spahn et al(30) conducted a prospective rando-
mized controlled study to compare radiofrequency 
and mechanical debridement for treating chondral 
lesions of the knee. They concluded that all the pa-
tients were benefited by both treatments, although 
the patients treated with radiofrequency had results 
that were better than those of patients treated by 
means of mechanical debridement, over the first year 
of follow-up. The results were determined by means 
of a variety of scoring methods, such as the Tegner, 
visual analogue and KOOS scales. 
Total cartilage defects – osteochondral defects
Abrasion
This is an arthroscopic technique for mechanical 
debridement using a motorized shaving device. It was 
first described as a palliative measure for attempting to 
avoid total knee arthroplasty in patients with osteoar-
throsis. It is thought that stimulation of the subchondral 
bone may release mesenchymal cells from the bone 
marrow, thus promoting formation of new tissue(31). 
Drilling
 This technique was developed by Pridie(32), with 
the assumption that creation of a large number of 
holes in the subchondral plate would promote for-
mation of fibrocartilage.
It is an arthroscopic technique that consists of sti-
mulating the bone marrow through drilling holes in 
the bone, of diameter approximately 2.0-2.5 mm, us-
ing a Kirschner wire. The clinical results did not differ 
from the findings using the abrasion technique(32).
microfracture
This is another arthroscopic technique for stimulat-
ing the bone marrow, by means of drilling holes in the 
bone, using specific tools with a tip in the shape of a 
sharp-pointed cone (Steadman Awl). This procedure 
was developed to regenerate the chondral defect. In 
microfractures, the osteochondral defect is firstly cau-
tiously curetted to remove the remains of the calcified 
layer of the cartilage, and then the surface is evened out 
to produce a uniform defect. Following this, holes are 
drilled in the bone using the tool with the conical tip, 
starting at the edge of the lesion and going towards the 
center, leaving spaces of 3 to 5 mm between the holes. 
It is important to note that in the microfracture tech-
nique, the hole penetration is approximately 3 mm(33). 
The intention with this technique is to promote for-
mation of a coagulum of mesenchymal cells coming 
from the bone medulla, which will be responsible for 
forming a fibrocartilaginous repair(33). 
The clinical results from microfractures are largely 
dependent on the patient’s age and the size of the car-
tilage defect. In young and active patients, microfrac-
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ture is recommended and has best long-term results in 
defects smaller than 2.5 cm²(34). It has been reported that 
the microfracture procedure resulted in pain relief for 
75% of the patients over long-term follow-up(34). In con-
trast, other studies have demonstrated that the clinical 
improvement starts to diminish after around two years 
after the operation, especially among older patients(35). 
Because of the easy surgical technique, the low cost 
and the good results, microfracture has been widely 
used(33). The best indication is for defects smaller than 
2 cm², but improvements in symptoms may also be 
achieved in defects of up to 4 cm². Better prognoses are 
found among young patients with defects in the femoral 
condyles. Less promising prognoses are found among pa-
tients with long-term lesions and high body mass index.
mosaicplasty
Autologous osteochondral transplantation or mo-
saicplasty is a technique in which one or more osteo-
chondral cylinders are removed from an area without 
offloading of weight for the area of the osteochondral 
defect (area with offloaded weight)(36). 
Mosaicplasty is an arthroscopic procedure that was 
first described by Hangody and Kárpati(37). It consists 
of three stages(38). The first stage is to prepare the 
receptor bed, which involves removing residual car-
tilage fragments from the chondral bed, down to the 
subchondral bone, followed by creation of cylindrical 
tunnels of depth 15 mm, with a spacing distance of 
1 mm between them. The diameter of the receptor 
bed should be 0.1 mm less than the diameter of the 
donor graft, such that it fits by being pressed in. The 
opening is constructed perpendicularly to the joint 
cartilage(37). The second stage is to harvest the graft, 
in cylindrical shape, with a length of 10-15 mm. The 
final stage is to insert the osteochondral plug into 
the receptor location. It has been demonstrated that 
different sizes of graft (5.5 to 10 mm) can be used in 
mosaicplasty(37). The best scenario is the possibility 
of using a single cylinder that completely fills the 
osteochondral defect.
Mosaicplasty aims to make use of good bone-to-
bone healing in order to facilitate cartilage healing. 
The authors  who conceived the technique suggested 
that it could be indicated for osteochondral defects 
of 1 to 4 cm²(39). However, the bigger the defect is, 
the larger the area removed from the donor site has 
to be, which limits the possibility of indicating this 
technique for larger defects. Despite the good results 
shown by Hangody and Füles(36) among patients over 
the age of 50 years, the success rate decreases sig-
nificantly among older patients. Another limitation 
of this technique is that between the transferred os-
teochondral cylinders, there are empty areas without 
cartilaginous repair, which may cause morbidity at 
the donor site(40).
Another issue that has been raised is the viability 
of chondrocytes from an area not subjected to loading 
that are transferred to an area with loading. At the-
se locations, changes to the cartilage structure, loss 
of viability and subsequent degeneration of the joint 
cartilage are observed(41).
The geometry of the cartilage in the osteochon-
dral defect is not always the same as in the donor 
site. Achieving the ideal geometry for the affected 
region in cases of larger defects is a challenge for 
the surgeon, especially when the procedure is done 
arthroscopically(42). 
Gudas et al(43) conducted a prospective study com-
paring mosaicplasty and microfracture among 70 
patients. The patients were evaluated by means of 
the ICRS score, HSS score, arthroscopy, histology, 
nuclear magnetic resonance and radiography. They 
concluded that there were statistically significant im-
provements in the ICRS and HSS scores among the 
patients who underwent mosaicplasty, in relation to 
the microfracture group, 12 months after the surgical 
procedure. At the end of the follow-up, it was observed 
that there had been deterioration in the microfracture 
group (Figure 3).
Allogenic osteochondral transplantation
Allogenic osteochondral grafts from cadavers are 
also a treatment option for osteochondral defects. This 
is similar to the mosaicplasty technique, but is used 
on larger defects. It has the advantage that it can be 
done with a single osteochondral cylinder. The dis-
advantages of allogenic transplantation include im-
munological rejection, failure of bone incorporation 
and non-viability of the chondrocytes(44). 
McCulloch et al(45) published a series of 25 cases 
of patients with osteochondral lesions who underwent 
allogenic osteochondral transplantation, with a two-
year follow-up. They found statistically significant 
improvements in the Lysholm, IKDC, KOOS and 
other scores; 84% of the patients were satisfied with 
the results and rated the functionality of the operated 
knee as 79%, in relation to the non-operated knee. 
Radiographically, 88% of the grafts became fully in-
corporated into the receptor bone. 
La Prade et al(46) published a prospective study on 
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Figure 3 - (A) Microfracture in the region of the femoral trochlea; 
(B) Mosaicplasty on  the medial femoral condyle.
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23 patients with osteochondral lesions in the femo-
ral condyle who underwent allogenic osteochondral 
transplantation, with a three-year follow-up. The pa-
tients were evaluated using the Cincinnati score be-
fore and after the operation, and the authors concluded 
that there was a significant improvement in this score. 
The allogenic osteochondral transplants, which had 
been stored under refrigeration for between 15 and 
28 days, provided significant clinical and functional 
improvements after a mean follow-up of three years, 
and the results were similar to those from historical 
reports on fresh allogenic osteochondral grafts. 
Autologous chondrocyte transplantation: first 
generation 
Since 1994, when Brittberg et al(47) published the 
first paper on implantation of chondrocytes for treat-
ing osteochondral defects, much has been developed 
in this area. Autologous chondrocyte transplantation 
to treat osteochondral defects is done as two surgical 
procedures. The first operation consists of cartilage bi-
opsy from a healthy area, done arthroscopically. From 
this cartilage fragment, chondrocytes are cultured in 
the laboratory. After the number of cells has grown, 
a second, open surgical procedure is performed to 
implant these chondrocytes. The region of the defect 
is prepared, the edges are evened out and the chon-
drocytes are kept at the site by means of a layer of 
periosteum sutured to the borders of the lesion(47).
The indications for autologous chondrocyte trans-
plantation are lesions bigger than 2 cm² and smaller 
than 12 cm², and patients who continue to present pain 
after mosaicplasty or microfracture. The rates of good and 
excellent results have been 92% in single lesions, 67% in 
multiple lesions, 89% in osteochondritis dissecans, 65% in 
the patella and 75% in lesions associated with reconstruc-
tion of the anterior cruciate ligament(48). Factors that place 
limitations on widespread use of this surgical technique 
include the need for two surgical procedures, hypertrophy 
of the periosteal membrane (symptomatic in 13% of the 
patients) and the high cost.
Knutsen et al(49) published a study on 80 symp-
tomatic patients with a single defect in the cartila-
ge of the femoral condyle who were divided into 
two groups: 40 patients who underwent autologous 
chondrocyte transplantation and 40 who underwent 
microfracture. They were evaluated using the ICRS, 
Lysholm, SF-36 and Tegner scores, along with radio-
graphic assessments using the Kellgren and Lawrence 
methods. It was concluded that after two to five years, 
both groups had achieved significant improvements, 
in comparison with their preoperative states. Both 
methods provided satisfactory results for 77% of the 
patients over a five-year period. There was no signifi-
cant difference between the clinical and radiographic 
results, and there was no correlation between the his-
tological findings and the clinical results. One third 
of the patients presented the first radiographic signs 
of osteoarthrosis five years after the surgery. 
Autologous chondrocyte transplantation: second 
and third generations
The second generation of autologous chondrocyte 
transplantation has advantages over the first genera-
tion, given that there is no need to use periosteum. 
This avoids the need for an additional incision, which 
would be made to extract it, as well as avoiding pos-
sible hypertrophy of the periosteum.
Furthermore, second-generation autologous chon-
drocyte transplantation uses a matrix for culturing 
chondrocytes that has characteristics resembling those 
of the extracellular matrix of the cartilage. The ma-
trixes available for use in Europe are: 1) MACI (Gen-
18
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zyme Biosur gery, Cambridge, MA, USA), which uses 
type I/III pig collagen and in which the chondrocytes 
are cultured three to four days before implantation; 2) 
Chondro-Gide (Geistlich Bio materials, Switzerland), 
which is similar to MACI; 3) Hyalograft C (Fidia 
Advanced Biopoly mers, Abano Terme, Italy), which 
is a three-dimensional matrix of hyaluronic acid that 
allows chondrocyte growth. The characteristics of 
these matrixes make it possible to perform the sur-
gery arthroscopically, thus avoiding joint arthrotomy.
Saris et al(50,51) published a randomized study com-
paring autologous chondrocyte transplantation using 
ChondroCelect (TiGenix NV, Leuven, Belgium) (57 
patients) with microfracture (61 patients), with 36 
months of follow-up. The results were evaluated using 
KOOS and nuclear magnetic resonance, and it was 
concluded that treatment of chondral lesions by means 
of autologous chondrocyte transplantation achieved 
a significantly better result over a 36-month period, 
compared with microfracture. 
Basad  et al(52) published a randomized study com-
paring MACI autologous chondrocyte transplantation 
(40 patients) with microfracture (20 patients). The 
patients treated with MACI achieved a significant 
improvement in relation to those who underwent mi-
crofracture. The technique using MACI represents a 
significant advance in comparison with the first gen-
eration of autologous chondrocyte transplantation 
because of its surgical simplicity, safety and repro-
ducibility. 
use of stem cells in treating chondral lesions of 
the knee
In 2007, Kuroda et al(53) published a case report in 
which a 31-year-old judo player with an osteochon-
dral lesion in the medial femoral condyle (classified 
as grade IV on the ICRS scale) was treated by means 
of using bone marrow cells. Arthroscopy performed 
seven months after the procedure found a defect co-
vered with smooth tissue and histologically filled by 
hyaline cartilage tissue that stained positively with 
safranin-O. The symptoms were found to have im-
proved significantly, one year after the surgery. 
Wakitini et al(54) published a study demonstrating 
the safety of autologous bone marrow cell transplanta-
tion for treating osteochondral defect, after 11 years 
and 5 months of follow-up. No occurrences of tumors 
or infections were observed during this follow-up, 
and the autologous bone marrow cell transplantation 
was considered to be a safe procedure. The stem cell 
transplantation was done either with a matrix or with 
a periosteal flap.
One-step stem cell transplantation
Giannini et al(55) published the first paper on stem 
cell transplantation in a single procedure (“One-Step”) 
for treating chondral lesions, which in this case were 
talar chondral lesions. In this procedure, bone mar-
row cells were aspirated and the material was cen-
trifuged to separate red cells and plasma from the 
nuclear cells. Through this process, nuclear cells such 
as stem cells, monocytes, lymphocytes and other cells 
residing in the bone marrow can be obtained. Pow-
dered collagen and a hyaluronic acid membrane were 
used as scaffolds for supporting the nuclear cells. In 
vitro preclinical tests were also performed in order to 
ascertain the capacity of the cells derived from bone 
marrow to differentiate into chondrogenic and osteo-
genic lineages. Forty-eight patients were evaluated 
with this technique, with a follow-up of two tears, and 
a significant improvement in functional scores was 
observed. The postoperative histological evaluation 
showed the presence of regenerated tissue at several 
stages of remodeling, although none of these patients 
subjected to histological examination presented fully 
hyaline cartilage. 
Along these lines, Gobbi et al(56) published the 
first case of stem cell transplantation using the one-
step procedure to operate on a knee, with two years 
of follow-up. The procedure consisted of using bone 
marrow cells together with scaffolds of types I and III 
collagen. The patients presented significant improve-
ments in all the scores evaluated, and tissue resem-
bling hyaline cartilage was found in the histological 
tests. No adverse reaction or postoperative complica-
tions were found. 
minced cartilage
The principle of the minced cartilage technique is to 
achieve hyaline cartilage through chondral lesion repair 
using minced “fragments” of hyaline cartilage from an 
uninjured area that does not bear weight, often of au-
tologous nature, complemented with a scaffold. A small 
quantity of minced cartilage creates sufficient chondro-
cytes to treat relatively large defects. Specifically, this 
technique requires only one tenth of the quantity of 
cartilage that originally filled the defect(57). 
The minced cartilage technique is attractive be-
cause it is performed as a single stage, using natu-
ral chondral tissue, and the minced cartilage can be 
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applied using arthroscopic techniques. Studies on 
animals and preclinical models have demonstrated 
the presence of hyaline cartilage after the repair has 
been completed. Scaffolding and fibrin glue have 
been shown to be important for the viability of this 
technique. Additional clinical data and basic scientific 
data are needed on the minced cartilage technique(57).
Criteria for choosing the surgical technique
Jones and Peterson(58) recommended that for le-
sions of 1 to 2.5 cm2, microfracture is a good treat-
ment option, as is mosaicplasty, provided that the 
graft is parallel to the joint surface. It is believed that 
microfractures can be used in less active patients, 
whereas in cases of patients who are more active, 
mosaicplas ty may provide better cartilage repair. For 
lesions bigger than 2 cm², autologous chondrocyte 
transplantation is the most indicated procedure(58). For 
lesions bigger than 4 cm², allogenic osteochondral 
transplantation is a good option(58). 
A systematic review conducted by Farr et al(59), 
which included 77 articles, provided some recom-
mendations and strategies for joint cartilage repair, 
in accordance with the current evidence (Table 2).
In a review on four randomized controlled studies, 
Bekkers et al(60) concluded that the size of the lesions, 
the level of activity and age were the parameters that 
most influenced the result from joint cartilage re-
pair surgery. Lesions larger than 2.5 cm² should be 
treated using sophisticated techniques such as au-
tologous chondrocyte transplantation or autologous 
osteochondral transplantation, while microfracture is 
a good treatment option for lesions smaller than 2.5 
cm². Active patients present better results after autolo-
gous chondrocyte transplantation or autologous os-
teochondral transplantation than after microfracture. 
Younger patients (< 30 years) seem to benefit more, 
independent of the type of cartilage repair surgery, 
than do patients over the age of 30 years. 
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